apomorphine has been researched along with amantadine in 96 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 77 (80.21) | 18.7374 |
1990's | 4 (4.17) | 18.2507 |
2000's | 8 (8.33) | 29.6817 |
2010's | 6 (6.25) | 24.3611 |
2020's | 1 (1.04) | 2.80 |
Authors | Studies |
---|---|
Gianutsos, G; Hane, JT; Henkel, JG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Pradhan, SN | 1 |
Freedman, DX; Halaris, AE | 1 |
Cox, B; Kastin, AJ; Schnieden, H | 1 |
Carroll, BJ; Curtis, GC; Kokmen, E | 1 |
Anand, M; Bhargava, KP; Gupta, GP | 1 |
Hungerbühler, JP; Regli, F | 1 |
Cox, B; Schnieden, H | 1 |
Dinnendahl, V; Gumulka, SW; Peters, HD; Schönhöfer, PS | 1 |
Lazarova, MB; Roussinov, KS | 1 |
Cox, B; Tha, SJ | 2 |
Lazarova, M; Roussinov, K | 1 |
Allen, RM; Flemenbaum, A | 1 |
Llados, F; Zapata, P | 1 |
Bartholini, G; Haefely, W; Pletscher, A | 1 |
Schechter, MD | 1 |
Senault, B | 1 |
Borsy, J; Dunai-Kovács, Z; Székely, JI | 1 |
Pakszys, W | 1 |
Cotzias, GC; Ginos, JZ; Papavasiliou, PS | 1 |
Costall, B; Naylor, RJ | 4 |
Bariletto, S; Dollar, E; Leitz, F | 1 |
Barnett, A; Goldstein, J | 1 |
Barnett, A; Goldstein, JM; Malick, JB | 1 |
Przewlocki, R | 1 |
Dandiya, PC; Kulkarni, SK | 1 |
Cox, B | 1 |
Maeda, N; Matsuoka, N; Yamaguchi, I | 1 |
Amdur, RL; Carvey, PM; Kao, LC; Klawans, HL; Lin, DH; Singh, R; Zhang, TJ | 1 |
Balsara, JJ; Bapat, TR; Chandorkar, AG; Gada, VP; Nandal, NV | 1 |
Ljungberg, T | 1 |
Fujiwara, M; Kamiya, H; Ono, N; Saito, R | 1 |
Alperina, E; Cheido, M; Devoino, L; Idova, G; Morozova, N | 1 |
Glebov, RN; Komissarov, IV; Zholob, GI | 1 |
Moore, KE; Von Voigtlander, PF | 1 |
Consolo, S; Garattini, S; Ladinsky, H | 1 |
Grewaal, DS; McGeer, EG; McGeer, PL | 1 |
Gressier, H; Malecot, E; Poignant, JC | 1 |
Lahti, RA; McAllister, B; Wozniak, J | 1 |
Bucher, MB; Schorderet, M | 1 |
Calne, DB; Reid, JL | 1 |
Julku, H; Lagerspetz, KY; Tarkkonen, H; Tirri, R | 1 |
Eigeman, L; Vaatstra, WJ | 1 |
Kadzielawa, K | 1 |
Dulska, E; Lacki, M; Wolfarth, S | 1 |
Ngai, SH | 1 |
Calne, DB; Hilson, A; Rao, SK; Vakil, SD | 1 |
Benesová, O | 1 |
Bianchine, JR; Sunyapridakul, L | 1 |
Spoerlein, MT; VanderWende, C | 1 |
Barnett, A; Fiore, JW | 1 |
Darnell, M; Koprowski, H; Lagerspetz, KY; Tarkkonen, H | 1 |
Cashin, CH; Sutton, S | 1 |
Davies, JA; Jackson, B; Redfern, PH | 2 |
Hackman, R; Neuvonen, PJ; Pentikainen, P; Vapaatalo, H | 1 |
Grabowska, M | 1 |
Papeschi, R; Randrup, A | 1 |
Baran, L; Maj, J; Sarnek, J; Sowińska, H | 1 |
Albert, E | 1 |
Korduba, CA; Symchowicz, S; Veals, J | 1 |
Haddox, VG; Menon, MK; Vivonia, CA | 1 |
Allen, RM | 1 |
Lee, MC | 1 |
Czuczwar, SJ; Kleinrok, Z; Kozicka, M | 1 |
Balsara, JJ; Chandorkar, AG; Dhavare, BS; Nandal, NV | 1 |
Kuribara, H; Tadokoro, S | 1 |
Alkana, RL; Birch, H; Cohen, HB; Malcolm, RD; Noble, EP; Parker, ES | 1 |
Westermann, KH | 1 |
Kleinrok, Z; Szurska, G | 1 |
Allen, RM; Brauchi, JT; Lane, JD | 1 |
Boismare, F; Leclerc, JL; Moore, N; Saligaut, C | 1 |
Katz, RJ; Schmaltz, K | 1 |
Stewart, RM | 1 |
Starr, BS; Starr, MS | 1 |
Oertel, WH; Quinn, NP | 1 |
Bhatia, KP; Münchau, A | 1 |
Hermans, E; Maloteaux, JM; Page, G; Peeters, M | 1 |
Ceballos-Baumann, A | 1 |
Sobolewski, P | 1 |
Goetz, CG; Poewe, W; Rascol, O; Sampaio, C | 1 |
Asmus, F; Bötzel, K; Deutschländer, A; Gasser, T; Klopstock, T; Marelli, E | 1 |
Brotchie, JM; Fox, SH; Gomez-Ramirez, J; Johnston, TH; Pires, D; Visanji, NP; Voon, V | 1 |
Fernandez, HH | 1 |
Bezard, E; Björklund, A; Carta, M; Li, Q; Pioli, EY; Porras, G; Tronci, E | 1 |
Bodart, O; Charland-Verville, V; Demertzi, A; Gosseries, O; Laureys, S; Thonnard, M | 1 |
Capone, JG; Contini, E; Golfre-Andreasi, N; Gragnaniello, D; Preda, F; Quatrale, R; Sensi, M; Sette, E; Tola, MR; Trevisani, L; Tugnoli, V | 1 |
Anheim, M; Grillon, A; Lipsker, D; Moegle, C; Velter, C | 1 |
19 review(s) available for apomorphine and amantadine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Aggression and central neurotransmitters.
Topics: Acetylcholinesterase; Aggression; Amantadine; Animals; Apomorphine; Brain; Carbachol; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine beta-Hydroxylase; Humans; Hydroxydopamines; Hydroxyindoleacetic Acid; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parasympatholytics; Pimozide; Tubocurarine | 1975 |
[Considerations in the drug treatment of parkinsonism (author's transl)].
Topics: Amantadine; Apomorphine; Bromocriptine; Dopamine; Ergolines; Extrapyramidal Tracts; Female; Humans; Levodopa; Male; Monoamine Oxidase Inhibitors; Neurotransmitter Agents; Parkinson Disease; Phosphodiesterase Inhibitors; Piribedil; Tremor | 1978 |
Monoaminergic drugs: general pharmacology.
Topics: Absorption; Amantadine; Amphetamine; Animals; Apomorphine; Brain; Catecholamines; Cats; Cattle; Deamination; Decarboxylation; Dogs; Half-Life; Haplorhini; Humans; Hydroxylation; Kinetics; Levodopa; Methylation; Mice; Rats | 1976 |
Antiparkinsonian drugs: pharmacological and therapeutic aspects.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Amantadine; Amphetamine; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Histamine H1 Antagonists; Humans; Mental Disorders; Methyldopa; Movement Disorders; Norepinephrine; Parasympatholytics; Serotonin; Synaptic Transmission | 1972 |
Parkinsonism, levodopa, and anesthesia.
Topics: Amantadine; Anesthesia; Animals; Apomorphine; Benperidol; Blood-Brain Barrier; Brain; Cardiovascular Diseases; Catecholamines; Dihydroxyphenylalanine; Dopamine; Fentanyl; Humans; Mice; Movement Disorders; Muscle Rigidity; Parkinson Disease; Psychoses, Substance-Induced; Pulmonary Edema; Rats | 1972 |
Augmenting the action of levodopa.
Topics: Amantadine; Antacids; Apomorphine; Carboxy-Lyases; Catechol O-Methyltransferase Inhibitors; Dihydroxyphenylalanine; Dopamine beta-Hydroxylase; Drug Synergism; Humans; Methyldopa; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease | 1972 |
[Review of current pharmacotherapy of Parkinsonism. Comprehensive review].
Topics: 5-Hydroxytryptophan; Amantadine; Anticonvulsants; Apomorphine; Benztropine; Carboxy-Lyases; Chemical Phenomena; Chemistry; Dihydroxyphenylalanine; Humans; Parasympatholytics; Parkinson Disease; Procyclidine; Trihexyphenidyl | 1973 |
Individualization of levodopa therapy.
Topics: Amantadine; Amphetamine; Anesthetics; Animals; Antihypertensive Agents; Apomorphine; Arrhythmias, Cardiac; Carbidopa; Depression, Chemical; Diet; Disulfiram; Drug Interactions; Drug Therapy, Combination; Endocrine Glands; Glaucoma; Humans; Hydrogen-Ion Concentration; Levodopa; Mice; Parasympatholytics; Parkinson Disease; Stomach | 1974 |
[Compounds stimulating central catecholamine receptors].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Brain; Catalepsy; Catecholamines; Clonidine; Dopamine; Extrapyramidal Tracts; Humans; Mice; Norepinephrine; Rats; Receptors, Adrenergic; Receptors, Drug; Stereotyped Behavior; Stimulation, Chemical | 1973 |
[Therapy and problems of parkinsonism].
Topics: Adult; Aged; Amantadine; Animals; Antidepressive Agents; Apomorphine; Brain Chemistry; Brain Stem; Dihydroxyphenylalanine; Female; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monoamine Oxidase Inhibitors; Parasympatholytics; Parkinson Disease; Parkinson Disease, Postencephalitic; Parkinson Disease, Secondary; Psychoses, Substance-Induced; Stereotaxic Techniques; Sympathomimetics | 1971 |
Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology.
Topics: Amantadine; Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Binding, Competitive; Butaclamol; Humans; Kinetics; Spiperone | 1983 |
Parkinson's disease: drug therapy.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Cholinergic Antagonists; Dopamine Agonists; Dyskinesia, Drug-Induced; Guidelines as Topic; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Selegiline; Treatment Outcome | 1997 |
Pharmacological treatment of Parkinson's disease.
Topics: Age Factors; Aged; Amantadine; Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Monoamine Oxidase Inhibitors; Parkinson Disease | 2000 |
[Diagnosis and treatment of Parkinson's syndrome. What is important for the general practitioner?].
Topics: Aged; Amantadine; Antiparkinson Agents; Apomorphine; Botulinum Toxins; Catechols; Cholinesterase Inhibitors; Clinical Trials as Topic; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Enzyme Inhibitors; Ergot Alkaloids; Family Practice; Female; Humans; Levodopa; Male; Nitriles; Parkinson Disease; Parkinson Disease, Secondary; Parkinsonian Disorders; Piperidines | 2003 |
[Treatment of Parkinson disease in patients with surgical problems].
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Health Status; Humans; Levodopa; Parkinson Disease; Postoperative Period | 2003 |
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004.
Topics: Amantadine; Antiparkinson Agents; Apomorphine; Benzophenones; Benzothiazoles; Bromocriptine; Cabergoline; Catechol O-Methyltransferase Inhibitors; Deep Brain Stimulation; Dihydroergocryptine; Ergolines; Fetal Tissue Transplantation; Globus Pallidus; Humans; Indans; Indoles; Levodopa; Lisuride; Mesencephalon; Monoamine Oxidase Inhibitors; Neurosurgical Procedures; Nitrophenols; Parkinson Disease; Pergolide; Piribedil; Pramipexole; Selegiline; Thiazoles; Tolcapone | 2005 |
Updates in the medical management of Parkinson disease.
Topics: Age Factors; Amantadine; Antiparkinson Agents; Apomorphine; Catechol O-Methyltransferase; Cholinergic Antagonists; Disease Progression; Dopamine Agents; Humans; Levodopa; Monoamine Oxidase; Parkinson Disease | 2012 |
Amantadine, apomorphine and zolpidem in the treatment of disorders of consciousness.
Topics: Amantadine; Apomorphine; Consciousness Disorders; Humans; Pyridines; Zolpidem | 2014 |
77 other study(ies) available for apomorphine and amantadine
Article | Year |
---|---|
Structure-anti-Parkinson activity relationships in the aminoadamantanes. Influence of bridgehead substitution.
Topics: Amantadine; Animals; Antiparkinson Agents; Mice; Motor Activity; Receptors, Dopamine; Structure-Activity Relationship | 1982 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Psychotropic drugs and dopamine uptake inhibition.
Topics: Amantadine; Animals; Antidepressive Agents; Apomorphine; Brain; Central Nervous System Stimulants; Cerebral Cortex; Corpus Striatum; Depression, Chemical; Dopamine; Fenfluramine; Humans; Hypothalamus; In Vitro Techniques; Norepinephrine; Psychotropic Drugs; Rats; Serotonin; Synaptosomes; Telencephalon; Tranquilizing Agents | 1975 |
A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Brain; Dopamine; Female; Humans; Levodopa; Mice; Motor Activity; MSH Release-Inhibiting Hormone; Rats; Receptors, Drug; Stereotyped Behavior; Time Factors | 1976 |
Paradoxical response to dopamine agonists in tardive dyskinesia.
Topics: Adrenergic alpha-Agonists; Adult; Amantadine; Apomorphine; Benztropine; Clozapine; Deanol; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Tolerance; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Levodopa; Physostigmine; Receptors, Dopamine; Reserpine; Stimulation, Chemical; Thioridazine | 1977 |
Modification of electroshock fighting by drugs known to interact with dopaminergic and noradrenergic neurons in normal and brain lesioned rats.
Topics: Aggression; Amantadine; Animals; Apomorphine; Brain; Ditiocarb; Dopamine; Electroshock; Humans; Imipramine; Levodopa; Male; Neurons; Norepinephrine; Rats; Reserpine | 1977 |
A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dose-Response Relationship, Drug; Drug Interactions; Fenclonine; Humans; Kinetics; Male; Methyltyrosines; Pimozide; Rats; Stereotyped Behavior | 1976 |
Effects of dopaminergic stimulants on cyclic nucleotide levels in mouse brain in vivo.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Benserazide; Brain; Cerebellum; Cyclic AMP; Cyclic GMP; Dopamine; Dose-Response Relationship, Drug; Humans; Isoquinolines; Levodopa; Male; Mice; Nucleotides, Cyclic; Stereotyped Behavior | 1976 |
On certain relationships between gamma-aminobutyric acid (GABA) and dopaminergic agents in pentylenetetrazol convulsions.
Topics: Amantadine; Animals; Apomorphine; Dextroamphetamine; Ditiocarb; Dopamine; Drug Interactions; gamma-Aminobutyric Acid; Haloperidol; Levodopa; Male; Mice; Pentylenetetrazole; Seizures | 1978 |
The role of dopamine and noradrenaline in temperature control of normal and reserpine-pretreated mice.
Topics: Amantadine; Animals; Apomorphine; Body Temperature; Body Temperature Regulation; Dextroamphetamine; Dopamine; Droxidopa; Esophagus; Female; Levodopa; Male; Mice; Mice, Inbred Strains; Norepinephrine; Reserpine; Time Factors | 1975 |
On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
Topics: 5-Hydroxytryptophan; Amantadine; Amphetamine; Animals; Apomorphine; Dopamine; Levodopa; Male; Mice; Pentylenetetrazole; Seizures; Serotonin | 1979 |
The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Rats; Receptors, Dopamine; Stereotyped Behavior | 1979 |
Effects of dopamine analogues and antagonists on carotid body chemosensors in situ.
Topics: Action Potentials; Amantadine; Animals; Apomorphine; Butyrophenones; Carotid Body; Cats; Chemoreceptor Cells; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Phenothiazines | 1978 |
Amphetamine discrimination as a test for anti-parkinsonism drugs.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Aporphines; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Male; Piribedil; Rats | 1977 |
[Amantadine: aggressive effect; effect on apomorphine-induced aggressivity in the rat].
Topics: Aggression; Amantadine; Animals; Apomorphine; Dose-Response Relationship, Drug; Humans; Rats | 1976 |
The effect of anti-parkinsonian drugs on chlorpromazine-induced depression of operant behaviour.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Atropine; Behavior, Animal; Chlorpromazine; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Phenothiazines; Rats; Trihexyphenidyl | 1976 |
[Interaction between L-dopa and other drugs].
Topics: Amantadine; Anti-Arrhythmia Agents; Apomorphine; Chlorpromazine; Drug Antagonism; Drug Interactions; Drug Synergism; Humans; Levodopa; Parkinson Disease; Tranquilizing Agents | 1976 |
Therapeutic approaches in Parkinson's disease: possible roles of growth hormone and somatostatin.
Topics: Amantadine; Apomorphine; Growth Hormone; Humans; Levodopa; Parkinson Disease; Somatostatin | 1976 |
A comparison of circling models for the detection of antiparkinson activity.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior; Brain; Dextroamphetamine; Dopamine; Haloperidol; Humans; Isoquinolines; Levodopa; Male; Methylphenidate; Methyltyrosines; Piperazines; Rats; Reserpine; Rotation; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra; Thalamic Nuclei | 1975 |
Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
Topics: Amantadine; Animals; Apomorphine; Behavior; Corpus Striatum; Dextroamphetamine; Dopamine; Extrapyramidal Tracts; Humans; Hypothalamus; Limbic System; Male; Memantine; Methyltyrosines; Motor Activity; Parkinson Disease; Rats; Reserpine; Reticular Formation; Stereotaxic Techniques; Stereotyped Behavior; Substantia Nigra | 1975 |
Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Catechols; Corpus Striatum; Dopamine; Haloperidol; Homovanillic Acid; Male; Methyltyrosines; Rats; Tritium; Tyrosine | 1975 |
Actions of dopaminergic agonists on motor function.
Topics: Amantadine; Animals; Apomorphine; Behavior; Dextroamphetamine; Disease Models, Animal; Dopamine Antagonists; Humans; Hyperkinesis; Levodopa; Methylphenidate; Motor Activity; Movement Disorders; Phenethylamines; Piribedil; Rats; Stereotyped Behavior; Tyrosine | 1975 |
Head-turning induced by electrical stimulation of the caudate nucleus and its antagonism by anti-parkinson drugs.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Benztropine; Caudate Nucleus; Depression, Chemical; Electric Stimulation; Humans; Levodopa; Male; Rats; Stereotyped Behavior; Trihexyphenidyl | 1975 |
The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Carbidopa; Hindlimb; Levodopa; Male; Methamphetamine; Muscle Rigidity; Rats; Reserpine; Scopolamine; Time Factors; Trihexyphenidyl | 1975 |
The effects of apomorphine and 1,3-dimethyl-5-aminoadamantane (DMAA) on ponto-geniculo-occipital (PGO) waves in cats.
Topics: Amantadine; Animals; Apomorphine; Benserazide; Cats; Dopamine; Electroencephalography; Geniculate Bodies; Memantine; Occipital Lobe; Serotonin | 1975 |
Influence of chemical stimulation of central dopaminergic system on the open field behaviour of rats.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Behavior, Animal; Benztropine; Brain; Dopamine; Levodopa; Male; Rats; Stimulation, Chemical | 1975 |
Amantadine and apomorphine: interactions on striatal dopamine receptors.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Homovanillic Acid; Humans; Monoamine Oxidase Inhibitors; Rats; Receptors, Drug; Stereotyped Behavior; Time Factors | 1975 |
Septohippocampal cholinergic pathway and penile erections induced by dopaminergic and cholinergic stimulants.
Topics: Amantadine; Animals; Apomorphine; Brain; Denervation; Dopamine Agents; Dose-Response Relationship, Drug; Hippocampus; Male; N-Methylscopolamine; Neural Pathways; Parasympathetic Nervous System; Parasympathomimetics; Penile Erection; Pilocarpine; Rats; Scopolamine; Scopolamine Derivatives; Sulpiride | 1990 |
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Dopamine; Drug Interactions; Haloperidol; Lithium; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Scopolamine; Stereotyped Behavior; Thioridazine | 1990 |
Effect of ergometrine on methamphetamine and apomorphine stereotypy in the guinea-pig.
Topics: Amantadine; Animals; Apomorphine; Drug Synergism; Ergonovine; Guinea Pigs; Humans; Male; Methamphetamine; Receptors, Dopamine; Stereotyped Behavior; Time Factors | 1985 |
Locomotion and stereotyped behaviours induced by 1-amino-3,5-dimethyladamantane (D 145) and apomorphine in the rat: a comparison.
Topics: Amantadine; Animals; Antipsychotic Agents; Apomorphine; Dose-Response Relationship, Drug; Drug Interactions; Male; Memantine; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1986 |
The effect of neurotransmitters on cataleptic behavior induced by PG D2 in rats.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Catalepsy; Dopamine; Fenclonine; Injections, Intraventricular; Levodopa; Male; Motor Activity; Neurotransmitter Agents; Norepinephrine; Prostaglandin D2; Prostaglandins D; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1987 |
Monoamines as immunomodulators: importance of suppressors and helpers of the bone marrow.
Topics: Adjuvants, Immunologic; Amantadine; Animals; Apomorphine; Biogenic Amines; Bone Marrow; Dopamine; Haloperidol; Hypothalamo-Hypophyseal System; Male; Mice; Mice, Inbred CBA; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; T-Lymphocytes, Helper-Inducer; T-Lymphocytes, Regulatory | 1986 |
[Effect of dopamine and dopamine mimetics on Na, K-ATPase of corpus striatum synaptosomes].
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Depression, Chemical; Dopamine; In Vitro Techniques; Piribedil; Rats; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Synaptosomes | 1985 |
Turning behavior of mice with unilateral 6-hydroxydopamine lesions in the striatum: effects of apomorphine, L-DOPA, amanthadine, amphetamine and other psychomotor stimulants.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Basal Ganglia; Behavior, Animal; Brain Chemistry; Central Nervous System Stimulants; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Hydroxydopamines; Male; Mice; Neurochemistry; Norepinephrine; Serotonin; Time Factors | 1973 |
Effect of several dopaminergic drugs and trihexyphenidyl on cholinergic parameters in the rat striatum.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Choline; Corpus Striatum; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Dopamine; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Piperazines; Rats; Time Factors; Trihexyphenidyl | 1974 |
Influence of noncholinergic drugs on rat striatal acetylcholine levels.
Topics: Acetylcholine; Acetylcholinesterase; Acetyltransferases; Amantadine; Animals; Anti-Anxiety Agents; Apomorphine; Benzodiazepines; Biological Assay; Brain Chemistry; Choline; Corpus Striatum; Depression, Chemical; Haloperidol; Levodopa; Male; Methamphetamine; Rats; Rats, Inbred Strains; Reserpine; Stimulation, Chemical; Tyrosine 3-Monooxygenase | 1974 |
Comparative effects of apomorphine, piribedil and other neurotropic agents on central analgesic-induced catatonia in the rat.
Topics: Amantadine; Analgesics, Opioid; Animals; Antiparkinson Agents; Apomorphine; Atropine; Benserazide; Benzyl Compounds; Catatonia; Dextroamphetamine; Dextromoramide; Dihydroxyphenylalanine; Dioxoles; Dose-Response Relationship, Drug; Humans; Male; Morphine; Piperazines; Pyrimidines; Rats; Time Factors; Trihexyphenidyl | 1974 |
Dopamine agonist and antagonist activities of piribedil (ET495)and its metabolites.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Atropine; Behavior, Animal; Caudate Nucleus; Dextroamphetamine; Dioxoles; Dopamine; Dopamine Antagonists; Drug Synergism; Haloperidol; Humans; Injections; Male; Methylphenidate; Motor Activity; Nialamide; Piperazines; Pyrimidines; Rats; Stereotyped Behavior; Sulfites | 1974 |
Apomorphine antagonism of the elevation of homovanillic acid induced by antipsychotic drugs.
Topics: Amantadine; Animals; Apomorphine; Brain; Chlorpromazine; Dopamine; Dose-Response Relationship, Drug; Drug Antagonism; Haloperidol; Homovanillic Acid; Mice; Morphine; Phenylacetates; Receptors, Adrenergic; Structure-Activity Relationship; Synaptic Transmission; Thiothixene; Tranquilizing Agents; Trifluoperazine | 1972 |
Apomorphine-induced accumulation of cyclic AMP in isolated retinas of the rabbit.
Topics: Adenylyl Cyclases; Amantadine; Animals; Apomorphine; Cyclic AMP; Dopamine; In Vitro Techniques; Mescaline; Rabbits; Retina; Stimulation, Chemical | 1974 |
Temperature regulation and brain monoamines.
Topics: Amantadine; Animals; Apomorphine; Body Temperature Regulation; Brain; Cold Temperature; Depression, Chemical; Dopamine; Hypothalamus; Mice; Mice, Inbred C3H; Models, Neurological; Norepinephrine; Oxygen Consumption; Phenotype; Serotonin; Stimulation, Chemical; Temperature; Thermoreceptors | 1974 |
Dopamine turnover in the rat corpus striatum: in vivo and in vitro studies on the action of amantadine.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Body Temperature; Chlorpromazine; Corpus Striatum; Dopamine; Male; Rats; Time Factors; Tritium; Tyrosine | 1974 |
Dopamine receptor in the reward system of the rat.
Topics: Amantadine; Animals; Apomorphine; Benzyl Compounds; Cortical Synchronization; Desipramine; Dihydroxyphenylalanine; Dopamine; Electrodes, Implanted; Electroencephalography; Haloperidol; Hydrazines; Hypothalamus; Levodopa; Male; Rats; Receptors, Drug; Reward; Self Stimulation; Time Factors | 1974 |
Comparison of the effects of the intranigral injections of cholinomimetics with systemic injections of the dopamine receptor stimulating and blocking agents in the rabbit.
Topics: Acetylcholine; Amantadine; Animals; Apomorphine; Atropine; Caudate Nucleus; Cerebral Cortex; Depression, Chemical; Electrodes, Implanted; Electroencephalography; Hippocampus; Humans; Injections; Locomotion; Methacholine Compounds; Neostigmine; Parasympathomimetics; Rabbits; Receptors, Cholinergic; Spirostans; Stereotyped Behavior; Stimulation, Chemical; Substantia Nigra; Time Factors | 1974 |
Role of dopaminergic receptors in morphine analgesia and tolerance.
Topics: Amantadine; Analgesia; Animals; Apomorphine; Dibenzothiazepines; Dopamine; Drug Synergism; Drug Tolerance; Male; Mice; Mice, Inbred Strains; Morphine; Perphenazine; Phenoxybenzamine; Receptors, Adrenergic; Serine; Spiro Compounds | 1973 |
The effect of antiparkinson drugs on the liguomandibular reflex in cats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Benztropine; Cats; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Haloperidol; Lingual Nerve; Mandibular Nerve; Phenoxybenzamine; Receptors, Drug; Reflex | 1973 |
Levodopa and related drugs.
Topics: Amantadine; Apomorphine; Dihydroxyphenylalanine; Humans; Hydrazines; Hypotension; Mental Disorders; Movement Disorders; Nausea; Parasympatholytics; Parkinson Disease; Pyridoxine | 1973 |
Thermoregulation in group B arbovirus-resistant and group B arbovirus-susceptible mice.
Topics: Amantadine; Animals; Apomorphine; Arbovirus Infections; Body Temperature; Body Temperature Regulation; Dopamine; Female; Genotype; Male; Mice; Mice, Inbred C3H; Norepinephrine; Oxygen Consumption; Serotonin; Temperature | 1973 |
The effect of anti-Parkinson drugs on catalepsy induced by -methyl-p-tyrosine in rats pretreated with intraventricular 6-hydroxydopamine.
Topics: Amantadine; Amphetamine; Animals; Antiparkinson Agents; Apomorphine; Benserazide; Benztropine; Brain Chemistry; Catalepsy; Dextroamphetamine; Dihydroxyphenylalanine; Humans; Hydroxydopamines; Methylphenidate; Methyltyrosines; Rats; Reserpine; Scopolamine | 1973 |
The effect of anti-Parkinsonian drugs on haloperidol-induced inhibition of the conditioned-avoidance response in rats.
Topics: Amantadine; Animals; Antiparkinson Agents; Apomorphine; Avoidance Learning; Benzilates; Conditioning, Psychological; Ethylamines; Haloperidol; Male; Propylamines; Rats; Receptors, Adrenergic; Time Factors | 1973 |
Inhibition of the apomorphine gnawing compulsion by amantadine.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Chlorpromazine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Synergism; Male; Metoclopramide; Rats | 1973 |
Effects of amantadine and L-dopa on apomorphine- and d-amphetamine-induced stereotyped behaviour in rats.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Dextroamphetamine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Drug Interactions; Female; Humans; Male; Rats; Statistics as Topic; Stereotyped Behavior; Time Factors | 1973 |
Catalepsy, sedation and hypothermia induced by alpha-methyl-p-tyrosine in the rat. An ideal tool for screening of drugs active on central catecholaminergic receptors.
Topics: Amantadine; Animals; Apomorphine; Behavior, Animal; Body Temperature; Brain Chemistry; Catalepsy; Depression, Chemical; Desipramine; Dextroamphetamine; Dihydroxyphenylalanine; Disulfides; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Exploratory Behavior; Humans; Hydrazines; Hypnotics and Sedatives; Male; Methyltyrosines; Motor Activity; Norepinephrine; Posture; Rats; Receptors, Drug; Scopolamine; Time Factors | 1973 |
The effect of amantadine, L-dopa, (plus)-amphetamine and apomorphine on the acquisition of the conditioned avoidance response.
Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Conditioning, Psychological; Depression, Chemical; Dextroamphetamine; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Male; Memory; Rats; Stimulation, Chemical; Time Factors | 1974 |
Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
Topics: Amantadine; Animals; Apomorphine; Blood Pressure; Body Temperature; Brain Chemistry; Catalepsy; Chlorpromazine; Dextroamphetamine; Disulfides; Dopamine; Female; Fluphenazine; Haloperidol; Humans; Imidazoles; Male; Methyltyrosines; Motor Activity; Norepinephrine; Oxotremorine; Parasympatholytics; Rats; Reflex; Reserpine; Spiro Compounds; Stereotyped Behavior | 1974 |
Inhibition of dopamine uptake into synaptosomes of rat corpus striatum by chlorpheniramine and its structural analogs.
Topics: Amantadine; Animals; Apomorphine; Brompheniramine; Chlorpheniramine; Cytoplasmic Granules; Diphenhydramine | 1971 |
Evidence for presynaptic antagonism by amantadine of indirectly acting central stimulants.
Topics: Amantadine; Animals; Apomorphine; Central Nervous System Stimulants; Dextroamphetamine; Ethanol; Male; Mice; Motor Activity; Pentobarbital; Receptors, Dopamine | 1984 |
Spasmodic torticollis and other idiopathic torsion dystonias. Medical management.
Topics: Adrenergic Agents; Amantadine; Antipsychotic Agents; Apomorphine; Benzodiazepines; Carbamazepine; Dystonia; Humans; Levodopa; Parasympatholytics; Torsion Abnormality; Torticollis | 1984 |
Effect of dopaminergic and GABA-ergic drugs given alone or in combination on the anticonvulsant action of phenobarbital and diphenylhydantoin in the electroshock test in mice.
Topics: Amantadine; Aminooxyacetic Acid; Amphetamine; Animals; Apomorphine; Baclofen; Dopamine; Electroshock; Female; Fluphenazine; gamma-Aminobutyric Acid; Haloperidol; Hydroxybutyrates; Levodopa; Male; Mice; Phenobarbital; Phenytoin; Receptors, Neurotransmitter; Seizures | 1980 |
Effects of L-histidine and promethazine on apomorphine and amantadine stereotypy in rats.
Topics: Amantadine; Animals; Apomorphine; Dose-Response Relationship, Drug; Histidine; Humans; Male; Promethazine; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1983 |
[Behavioral effects of amantadine on ambulatory activity and drinking in mice and on continuous and discrete avoidance responses in rats].
Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Central Nervous System Agents; Circadian Rhythm; Dose-Response Relationship, Drug; Drinking Behavior; Male; Methamphetamine; Mice; Motor Activity; Rats; Rats, Inbred Strains | 1984 |
Interaction of apomorphine and amantadine with ethanol in men.
Topics: Adult; Affect; Alcoholic Intoxication; Amantadine; Apomorphine; Attention; Double-Blind Method; Drug Synergism; Ethanol; Humans; Male; Mental Recall; Motor Skills; Receptors, Cholinergic; Receptors, Dopamine | 1982 |
Supersensitivity following repeated administration of dopaminergic agonists.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Cocaine; Dopamine; Exploratory Behavior; Female; Humans; Motor Activity; Rats; Rats, Inbred Strains; Stereotyped Behavior | 1982 |
[Effect of the stimulators and inhibitors of the central dopaminergic structures on the kininogen level and kallikrein activity in the rat plasma].
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Chlorpromazine; Haloperidol; Kallikreins; Kininogens; Male; Rats; Receptors, Dopamine; Reserpine | 1980 |
Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Topics: Amantadine; Animals; Apomorphine; Corpus Striatum; Haloperidol; Humans; In Vitro Techniques; Kinetics; Rats; Receptors, Dopamine; Spiperone; Stereotyped Behavior | 1980 |
Dopaminergic agonists and conditioned avoidance response in normoxic or hypoxic rats.
Topics: Amantadine; Animals; Apomorphine; Avoidance Learning; Bromocriptine; Dopamine; Female; Hypoxia; Piribedil; Rats | 1981 |
Dopaminergic involvement in attention. A novel animal model.
Topics: Amantadine; Animals; Apomorphine; Attention; Dopamine; Male; Mice | 1980 |
Parkinson's disease: new treatments.
Topics: Acetylcholine; Amantadine; Apomorphine; Bromocriptine; Carbidopa; Counseling; Dopamine; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neurologic Manifestations; Parkinson Disease; Physical Therapy Modalities; Receptors, Dopamine; Thalamus | 1981 |
Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amantadine; Animals; Apomorphine; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Locomotion; Male; Mice; Mice, Inbred Strains; Motor Activity; Phenethylamines; Receptors, Glutamate; Reserpine | 1995 |
Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine.
Topics: Amantadine; Animals; Apomorphine; Carbachol; Cholinergic Agonists; Corpus Striatum; Dopamine Agents; Excitatory Amino Acid Antagonists; Male; Motor Activity; Rats; Rats, Wistar; Receptors, Dopamine; Receptors, N-Methyl-D-Aspartate; Stereotyped Behavior; Synaptic Transmission | 2002 |
Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.
Topics: Administration, Oral; Amantadine; Antiparkinson Agents; Apomorphine; Combined Modality Therapy; Deep Brain Stimulation; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Hypokinesia; Infusions, Intravenous; Injections, Subcutaneous; Levodopa; Middle Aged; Neurologic Examination; Optic Atrophy; Parkinson Disease | 2006 |
Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amantadine; Animals; Antiparkinson Agents; Apomorphine; Behavior, Animal; Callithrix; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Dyskinesia, Drug-Induced; Female; Grooming; Hallucinations; Levodopa; Parkinsonian Disorders; Psychomotor Agitation; Psychotic Disorders; Statistics, Nonparametric; Stereotyped Behavior | 2006 |
Study of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
Topics: Amantadine; Amphetamine; Animals; Apomorphine; Disease Models, Animal; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Levodopa; Macaca fascicularis; Medial Forebrain Bundle; Motor Activity; Oxidopamine; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Serotonin Receptor Agonists; Time Factors; Tyrosine 3-Monooxygenase | 2013 |
Emerging issues on selection criteria of levodopa carbidopa infusion therapy: considerations on outcome of 28 consecutive patients.
Topics: Aged; Amantadine; Antiparkinson Agents; Apomorphine; Carbidopa; Caregivers; Drug Administration Routes; Drug Combinations; Drug Delivery Systems; Female; Follow-Up Studies; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Patient Selection; Retrospective Studies; Severity of Illness Index; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2014 |
Impulse control disorder-linked hypersexuality complicated by disseminated gonococcal infection in a patient with Parkinson's disease.
Topics: Amantadine; Apomorphine; Compulsive Behavior; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agonists; Female; Gonorrhea; Humans; Levodopa; Middle Aged; Parkinson Disease; Sexual Dysfunctions, Psychological; Tetrahydronaphthalenes; Thiophenes | 2020 |